Philippe Archinard

Philippe Archinard is Executive Vice President, Technological Innovation and Scientific Partnership of Institut Mérieux after having been Chairman and Chief Executive Officer of Transgene, of which he is still a director. He is also Chairman of Institut de Recherche Technologique BIOASTER and Chief Executive Officer of TSGH, a company of the Institut Mérieux Group, as well as a director of bioMérieux SA, ERYtech Pharma, NH TherAguix and ABL Inc, where he is the permanent representative of TSGH. He was previously President of bioMérieux Inc. (USA), Executive Vice President of bioMérieux SA and Chief Executive Officer of Innogenetics BV. Philippe Archinard is a graduate of the Harvard Business School.